Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and-4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves
Lj. Gershwin et al., Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and-4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves, AM J VET RE, 61(3), 2000, pp. 291-298
Objective-To study the local immune response of calves to bovine respirator
y syncytial virus (BRSV) infection with emphasis on IgE production and cyto
kine gene expression in pulmonary lymph.
Animals-Twelve 6- to 8-week-old Holstein bull calves, Six similar control c
alves were mock infected to obtain control data.
Procedure-Lymphatic cannulation surgery was performed on 12 calves to creat
e a long-term thoracic lymph fistula draining to the exterior. Cannulated c
alves were exposed to virulent BRSV by aerosol. Lymph fluid collected daily
was assayed for BRSV acid isotype-specific IgE antibody, total IgG, IgA, I
gM, and protein concentrations, interleukin-4 (IL-4), interleukin-2 (IL-2),
and interferon-gamma were semi-quantitated by reverse transcription-polyme
rase chain reaction (RT-PCR), Cell counts and fluorescence-activated cell s
canner (FACSCAN) analysis of T-cell subsets were performed on lymph cells.
Results-Calves had clinical signs of respiratory tract disease during days
5 to 10 after infection and shed virus. Bovine respiratory syncytial virus-
specific IgE in infected calves was significantly increased over baseline o
n day 9 after infection. Mean virus-specific IgE concentrations strongly co
rrelated with increases in severity of clinical disease (r = 0.903). Expres
sion of IL-2, IL-4, and interferon-gamma was variably present in infected a
nd control calves, with IL-4 expression most consistent during early infect
ion.
Conclusions and Clinical Relevance-Infection with BRSV was associated with
production of BRSV-specific IgE, and IL-4 message was commonly found in lym
ph cells of infected calves, This finding supports the concept that BRSV-in
duced pathophysiology involves a T helper cell type-2 response. Effective t
herapeutic and prophylactic strategies could, therefore, be developed using
immunomodulation to shift the immune response more toward a T helper cell
type-1 response.